Extrahepatic Cholangiocarcinoma — Trials

Extrahepatic Cholangiocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

98 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 29
Recruiting: 19
Ph III recruiting: 1
Growth YoY: —
Industry share: 3%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (10)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06923475	Neoadjuvant Gemcitabine and Cisplatin in Combination With Perioperative Pembrolizumab Versus Upfront Surgery for Patients With Primary Resectable and Borderline Resectable Perihilar and Distal Cholangiocarcinoma(NEODISCO)	recruiting	Phase 2 / Phase 3	150	Amsterdam UMC, location VUmcOTHER	1	Aug 25, 2026	clinicaltrials
NCT07765433	Testing the Addition of Ivonescimab Combined With Standard Chemotherapy Compared to the Usual Chemotherapy and Immunotherapy Treatment for Patients With Advanced Biliary Tract Cancer	not yet recruiting	Phase 2 / Phase 3	336	ECOG-ACRIN Cancer Research Group